These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12489616)

  • 1. Pharmacist ambivalence about sale of syringes to injection drug users.
    Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka T; Corsi KF; Tindall MS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S52-7. PubMed ID: 12489616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection drug users report good access to pharmacy sale of syringes.
    Reich W; Compton WM; Horton JC; Cottler LB; Cunningham-Williams RM; Booth R; Singer M; Leukefeld C; Fink J; Stopka TJ; Corsi KF; Tindall MS
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S68-72. PubMed ID: 12489619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.
    Lewis BA; Koester SK; Bush TW
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S46-51. PubMed ID: 12489615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The legality of selling or giving syringes to injection drug users.
    Burris S; Vernick JS; Ditzler A; Strathdee S
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island.
    Rich JD; Martin EG; Macalino GE; Paul RV; McNamara S; Taylor LE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S58-61. PubMed ID: 12489617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
    Vorobjov S; Uusküla A; Abel-Ollo K; Talu A; Jarlais DD
    J Urban Health; 2009 Nov; 86(6):918-28. PubMed ID: 19921542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' attitudes and practices about selling syringes to people who inject drugs in Tajikistan: Results of a syringe purchase audit and a survey.
    Ibragimov U; Haardörfer R; Cooper HLF; Dunkle KL; Zule WA; Wong FY
    Int J Drug Policy; 2019 Sep; 71():62-72. PubMed ID: 31226505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.
    Goodin A; Fallin-Bennett A; Green T; Freeman PR
    Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.
    Coffin PO; Ahern J; Dorris S; Stevenson L; Fuller C; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S62-7. PubMed ID: 12489618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.
    Gleghorn AA; Gee G; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law.
    Case P; Beckett GA; Jones TS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S94-101. PubMed ID: 9663631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
    Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
    J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia.
    Taussig J; Junge B; Burris S; Jones TS; Sterk CE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S40-5. PubMed ID: 12489614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users.
    Blumenthal WJ; Springer KW; Jones TS; Sterk CE
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S34-9. PubMed ID: 12489613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy nonprescription syringe distribution and HIV/AIDS: a review.
    Janulis P
    J Am Pharm Assoc (2003); 2012; 52(6):787-97. PubMed ID: 23229966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.